Loading clinical trials...

UNKNOWNNANCT03101423

Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism

Hematopoietic stem cell transplantation is currently the only way to cure thalassemia, one of its main obstacles is the rejection after transplantation, chimerism continued to decline, which eventuall...

Lead sponsor: First Affiliated Hospital of Guangxi Medical University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Inspiratory Muscle Training in Children With Beta Thalasemia

NCT06466304 · Beta Thalassemia Major

COMPLETED

ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

NCT06831799 · Hemoglobinopathies, Sickle Cell Disease, and more

WITHDRAWNEARLY Phase 1

Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies

NCT04776850 · Beta Thalassemia Major, Sickle Beta 0 Thalassemia, and more

UNKNOWNPhase 3

PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders

NCT04353986 · HCV Infection, Beta Thalassemia Major

UNKNOWNNA

Thrombin Generation in Beta-thalassemia Major

NCT04962984 · Beta Thalassemia Major Anemia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 28, 2018Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment30

Start dateAug 2016

Last updatedAug 28, 2018

Condition

Beta Thalassemia Major

Locations shown

the First Affiliated Hospital of Guangxi Medical University

Nanning, Guangxi

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 28, 2018Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions